Gamelin Erick bought ACRV
March 1, 2026 · Form 4 insider transaction
Gamelin Erick bought 94,946 shares of Acrivon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
94,946
Price
$0.00
Total value
N/A
InsiderGamelin Erick
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after94,946
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2027, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.